相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
Matthieu Mahevas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Cellular immune dysfunction in immune thrombocytopenia (ITP)
Christopher G. J. McKenzie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Current management of immune thrombocytopenia
Cindy E. Neunert
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Sequence of treatments for adults with primary immune thrombocytopenia
James N. George
AMERICAN JOURNAL OF HEMATOLOGY (2012)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis
Sophie Auger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders
Daan Dierickx et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Rapid Development of Infusion-Related Severe Hypotension During Rituximab Therapy
Kevin H Vo et al.
ANNALS OF PHARMACOTHERAPY (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Risk Factors for Severe Infections in Patients With Rheumatoid Arthritis Treated With Rituximab in the AutoImmunity and Rituximab Registry
J. -E. Gottenberg et al.
ARTHRITIS AND RHEUMATISM (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases
Nichola Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Low-dose rituximab in adult patients with primary immune thrombocytopenia
Francesco Zaja et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
A Woman with Lethargy, Confusion, and Abnormalities on Brain Imaging Progressive multifocal leukoencephalopathy.
Nagagopal Venna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rituximab-Associated Neutropenia
Kieron Dunleavy et al.
SEMINARS IN HEMATOLOGY (2010)
Repeated courses of Rituximab in chronic ITP: Three different regimens
Aisha Hasan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma
Gillianne Geet Yi Lai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin
Nichola Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis
Sercan Aksoy et al.
LEUKEMIA & LYMPHOMA (2009)
The late adverse events of rituximab therapy - rare but there!
Ron Ram et al.
LEUKEMIA & LYMPHOMA (2009)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults
Drew Provan et al.
HAEMATOLOGICA (2007)
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
Roberto Stasi et al.
BLOOD (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab
PM Millward et al.
TRANSFUSION (2005)
Treatment of childhood autoimmune haemolytic anaemia with rituximab
P Quartier et al.
LANCET (2001)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)
分享论文
